[Healthcare Is Broken: A New Report Says Patient Advocacy Is The Answer](https://wbbsec.com/opinions-and-features/healthcare-is-broken-a-new-report-says-patient-advocacy-is-the-answer/?preview_id=2921&preview_nonce=6cb73eef4a&post_format=standard&_thumbnail_id=2579&preview=true)
[Healthcare Is Broken: A New Report Says Patient Advocacy Is The Answer](https://wbbsec.com/opinions-and-features/healthcare-is-broken-a-new-report-says-patient-advocacy-is-the-answer/?preview_id=2921&preview_nonce=6cb73eef4a&post_format=standard&_thumbnail_id=2579&preview=true)
  •   (858) 592-9901
  •   [email protected]
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute

Opinions & Features

The Three Things Ken Burns Gets Wrong About Cancer

By:WBB SecuritiesPosted: Apr 3rd, 2015In: Opinions & Features

Rather than focusing on the noble quest of a few scientists and physicians, we must face the reality that cancer is a business.

Read More about The Three Things Ken Burns Gets Wrong About Cancer

Nightmare Bacteria And Dirty Scopes: Ignorance And Want In Medicine

By:WBB SecuritiesPosted: Feb 20th, 2015In: Opinions & Features

A deadly strain of antibiotic-resistant bacteria, dubbed “nightmare bacteria” by the head of the Centers for Disease Control and Prevention (CDC), has struck again.

Read More about Nightmare Bacteria And Dirty Scopes: Ignorance And Want In Medicine

Obama’s New Healthcare Proposal: A Precise Vision Or A Political Football

By:WBB SecuritiesPosted: Feb 4th, 2015In: Opinions & Features

When President Obama unveiled his Precision Medicine Initiative, he declared a two-fold challenge.

Read More about Obama’s New Healthcare Proposal: A Precise Vision Or A Political Football

Harvard Professors Balk As Obamacare Comes To Cambridge

By:WBB SecuritiesPosted: Jan 9th, 2015In: Opinions & Features

Challenging Obamacare is sure to be one of the top priorities of the newly convened 2015 Congress.

Read More about Harvard Professors Balk As Obamacare Comes To Cambridge

Analyst Interview with Steve Brozak: Will Biotech Fire on All Cylinders in 2015?

By:WBB SecuritiesPosted: Dec 31st, 2014In: Opinions & Features

Making predictions for the New Year may feel as productive as peering into a crystal ball. But in the life sciences, hard science and long experience back prognostication.

Read More about Analyst Interview with Steve Brozak: Will Biotech Fire on All Cylinders in 2015?

Merck Triggers The Race to Replace Cubist

By:WBB SecuritiesPosted: Dec 8th, 2014In: Opinions & Features

A real healthcare crisis has been in the works for the last half-century and it has nothing to do with the cost of healthcare, although you could argue it has something to do with the[...]

Read More about Merck Triggers The Race to Replace Cubist

And The Winners Are Actavis, Allergan And Ackman

By:WBB SecuritiesPosted: Nov 17th, 2014In: Opinions & Features

With White Knight Actavis standing in its corner, Allergan was able to outmaneuver Valeant Pharmaceuticals and Bill Ackman’s hedge fund, Pershing Square Capital, breaking a seven-month siege of the company.

Read More about And The Winners Are Actavis, Allergan And Ackman

Can Actavis Break The Siege Of Allergan?

By:WBB SecuritiesPosted: Nov 13th, 2014In: Opinions & Features

The Allergan saga just became the stuff of George R.R. Martin novels.

Read More about Can Actavis Break The Siege Of Allergan?

Does the GI Bill even work?

By:WBB SecuritiesPosted: Nov 11th, 2014In: Opinions & Features

Over the last 12 months, failures in the VA healthcare system have dominated reporting about the Veterans Administration.

Read More about Does the GI Bill even work?

Stopping Ebola: Mali Matters; Maine and Manhattan Don’t

By:WBB SecuritiesPosted: Oct 30th, 2014In: Opinions & Features

This has been an attention-grabbing week for Ebola in America.

Read More about Stopping Ebola: Mali Matters; Maine and Manhattan Don’t
Load More

Recent News

  • Healthcare Is Broken: A New Report Says Patient Advocacy Is The Answer October 20, 2026
  • What Price Healthcare? RevMed’s Rasonque—The US Drug Pricing Paradox September 8, 2026
  • New Forbes Article by Dr. Steve Brozak — Is Warren Buffett’s Stock Gambling Warning Bad for Biotechnology? July 21, 2026
  • Dr. Steve Brozak Reviews The Code as Witness in Forbes June 9, 2026
  • Deaths, Burned Clinics—What’s Different About Ebola’s 2026 Return? – Published in Forbes May 25, 2026

20 Commerce Dr.
Ste. 135
Cranford, NJ 07016

3111 Camino Del Rio N.
Ste. 400
San Diego, CA 92108

Copyright © 2026 WBB Securities, LLC. All Rights Reserved. Member FINRA/SIPC, BrokerCheck

  • Form CRS
  • Disclosures
  • Privacy Policy
Menu Bottom